As PharmEasy’s valuation slumps, Temasek Holdings, TPG, Prosus, CDPQ, Eight Roads, LGT, Abu Dhabi sovereign wealth fund ADQ, Amansa, OrbiMed and Sunil Kant Munjal’s family office to invest as much as Rs 2,000 crore, according to media reports.

Omnichannel pharmacy chain PharmEasy will raise Rs 3,500 crore through a rights issue next week, multiple people aware of the development said, helping it repay a big chunk of its loans to Goldman Sachs.

API Holdings, the parent entity of debt-laden PharmEasy, reportedly decided to raise Rs 2,000 crore to 3,000 crore via a rights issue, during an all-investor meeting held on Monday (July 17), to repay the loan it took from Goldman Sachs.

Temasek Holdings, TPG, Prosus, CDPQ, Eight Roads, LGT, Abu Dhabi sovereign wealth fund ADQ, Amansa, OrbiMed and Sunil Kant Munjal’s family office have already committed to invest as much as Rs 2,000 crore